A Preference Evaluation of Nasonex Nasal Spray (Unscented) vs. Flonase Nasal Spray (Scented) in Subjects With Symptomatic Allergic Rhinitis (AR) - Single-Dose Cross-over

Trial Profile

A Preference Evaluation of Nasonex Nasal Spray (Unscented) vs. Flonase Nasal Spray (Scented) in Subjects With Symptomatic Allergic Rhinitis (AR) - Single-Dose Cross-over

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Mometasone (Primary) ; Fluticasone propionate
  • Indications Allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 22 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top